# A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm

> **NCT04766723** · PHASE2 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 78 (actual)

## Conditions studied

- Essential Tremor of the Upper Limb

## Interventions

- **DRUG:** NT 201
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04766723
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-24
- **Primary completion:** 2023-04-26
- **Final completion:** 2023-11-21
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04766723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04766723, "A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04766723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*